Physician profile
Robert M Lea
NPI 1548205339
$751.96
in general payments reported to CMS, 2019-2025
9 companies · $220 in 2025
The $220 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $27.18 · 2023: $93.32 · 2024: $411 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $588 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $587.77 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $249.66 | 2023-2025 | Starling System, Tisseel, Perclot |
| Ethicon US, LLC | $207.36 | 2024-2025 | Stratafix, Evarrest, Surgicel Nu-Knit |
| Medical Device Business Services, INC. | $137.01 | 2024 | Surgicel Nu-Knit |
| Avita Medical Americas, LLC | $48.39 | 2025 | Cohealyx, Permeaderm, Recell |
| Integra Lifesciences Corporation | $27.18 | 2022 | |
| Smith+Nephew, INC. | $24.77 | 2024 | Collagenase Santyl |
| Solventum Corporation | $22.64 | 2024 | Prevena, V.A.C. Veraflo Cleanse Choice, V.A.C.Ulta |
| Kci USA, INC. | $19.01 | 2023 | V.A.C. Veraflo, Abthera, Prevena |
| Becton, Dickinson and Company | $15.94 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Lea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.